The adipose tissue-derived factor leptin has been emerged as a key regulator of nutritional state and metabolism, as well as a modulator of immune system activation and innate-adaptive frontier; thus bridging obesity with metabolic disorders (T2DM and NAFLD) and inflammatory pathologies that affect bones and joints (OA and RA). Here, LEP is linked to type 2 diabetes mellitus.